This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
10mg | $190 | To Be Confirmed |
25mg | $345 | To Be Confirmed |
50mg | $530 | To Be Confirmed |
100mg | $850 | To Be Confirmed |
250mg | $1550 | To Be Confirmed |
Cat #: V5332 CAS #: 79778-41-9 Purity ≥ 98%
Description: Neridronate (also known as Neridronic acid) is an aminobisphosphonate used in Italy for the treatment of osteogenesis imperfecta (OI) and Paget’s disease of bone (PDB). Neridronate is effective also in other skeletal diseases such as osteoporosis, algodystrophy, hypercalcemia of malignancy, and bone metastases. Neridronic acid, also known neridronate, is a bisphosphonate. Neridronic acid treatment has been reported to be effective also in other skeletal diseases such as osteoporosis, algodystrophy, hypercalcemia of malignancy and bone metastasis. Neridronic acid has been developed only for parenteral use, and it is the only one used as intramuscular injection.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
CAS No. | 79778-41-9 |
---|---|
Storage | -20℃ for 3 years in powder form |
-80℃ for 2 years in solvent |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.